Tourmaline Bio Inc
(TRML)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TRML | EVO | XERS | ||
| Company | Tourmaline Bio Inc | Evotec Se | Xeris Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 47.98 | 3.53 | 7.22 | ||
| High | 48.00 | 3.53 | 7.26 | ||
| Low | 47.98 | 3.47 | 6.86 | ||
| Latest | 47.98 | 3.48 | 6.91 | ||
| Change | unch | -0.12 | -0.31 | ||
| % Change | unch | -3.33% | -4.29% | ||
| Volume | 783,700 | 258,400 | 1,309,100 | ||
| 20-Day Average Volume | 653,225 | 123,340 | 1,419,630 | ||
| Previous Close | 47.98 | 3.60 | 7.22 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 47.90 | 3.61 | 7.32 | ||
| 20-Day Raw Stochastic | 92.00% | 22.73% | 6.93% | ||
| 20-Day Relative Strength | 88.61 | 49.35 | 43.35 | ||
| Weighted Alpha | +50.87 | -14.74 | +67.82 | ||
| Today's Opinion | 100% Buy | 40% Sell | 16% Sell | ||
| Previous Opinion | 100% Buy | 8% Sell | 16% Sell | ||
| Last Month's Opinion | 100% Buy | 8% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 10/20/25 | -6.45% since 02/04/26 | -2.40% since 02/04/26 | ||
| Low | 47.90 on 10/21/25 | 3.47 on 02/11/26 | 6.84 on 02/05/26 | ||
| High | 48.00 on 10/27/25 | 3.69 on 02/09/26 | 7.26 on 02/11/26 | ||
| 1-Month | |||||
| %Chg | +0.50% since 09/26/25 | -4.92% since 01/09/26 | -12.86% since 01/09/26 | ||
| Low | 47.75 on 09/30/25 | 3.38 on 02/02/26 | 6.84 on 02/05/26 | ||
| High | 48.27 on 09/29/25 | 3.87 on 01/13/26 | 7.97 on 01/12/26 | ||
| 3-Month | |||||
| %Chg | +142.69% since 07/25/25 | +17.17% since 11/11/25 | -7.12% since 11/11/25 | ||
| Low | 19.75 on 08/08/25 | 2.86 on 12/09/25 | 6.47 on 12/05/25 | ||
| High | 48.27 on 09/29/25 | 3.87 on 01/13/26 | 8.42 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | +184.07% since 04/25/25 | -8.66% since 08/11/25 | -4.03% since 08/11/25 | ||
| Low | 13.27 on 05/20/25 | 2.86 on 12/09/25 | 6.47 on 12/05/25 | ||
| High | 48.27 on 09/29/25 | 4.27 on 10/27/25 | 10.08 on 11/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,232,702 | 1,279,058 | 1,197,971 | ||
| Shares Outstanding, K | 25,692 | 355,294 | 165,924 | ||
| Annual Sales | 0 | 862,400,000 | 203,070,000 | ||
| Annual Net Income | -73,210,000 | -212,180,000 | -54,840,000 | ||
| Last Quarter Sales | 0 | 191,570,000 | 74,380,000 | ||
| Last Quarter Net Income | -23,090,000 | -50,360,000 | 620,000 | ||
| 60-Month Beta | 2.27 | 1.81 | 0.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.90 on 08/13/25 | N/A on 11/05/25 | 0.00 on 11/06/25 | ||
| Latest Earnings Date | 11/06/25 | 11/05/25 | 03/02/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||